EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition

Friedrich G Kapp, Farhad Bazgir, Nagi Mahammadzade, Mehrnaz Mehrabipour, Erik Vassella, Sarah M Bernhard, Yvonne Döring, Annegret Holm, Axel Karow, Caroline Seebauer, Natascha Platz Batista da Silva, Walter A Wohlgemuth und 9 weitere

Angiogenesis · 2024-11 · 27 (4) · 739-752

DOI: 10.1007/s10456-024-09934-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiogenesis, online erschienen am 05.07.2024. Verfasst von Friedrich G Kapp und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center-University of Freiburg, Faculty of Me…. Hauptthemen laut MEDLINE: Zebrafish, Arteriovenous Malformations, ras Proteins, MAP Kinase Signaling System. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, DFG Walter Benjamin Fellowship, German Federal Ministry of Education and Research (BMBF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arteriovenous malformations (AVM) are benign vascular anomalies prone to pain, bleeding, and progressive growth. AVM are mainly caused by mosaic pathogenic variants of the RAS-MAPK pathway. However, a causative variant is not identified in all patients. Using ultra-deep sequencing, we identified novel somatic RIT1 delins variants in lesional tissue of three AVM patients. RIT1 encodes a RAS-like protein that can modulate RAS-MAPK signaling. We expressed RIT1 variants in HEK293T cells, which led to a strong increase in ERK1/2 phosphorylation. Endothelial-specific mosaic overexpression of RIT1 delins in zebrafish embryos induced AVM formation, highlighting their functional importance in vascular development. Both ERK1/2 hyperactivation in vitro and AVM formation in vivo could be suppressed by pharmacological MEK inhibition. Treatment with the MEK inhibitor trametinib led to a significant decrease in bleeding episodes and AVM size in one patient. Our findings implicate RIT1 in AVM formation and provide a rationale for clinical trials with targeted treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishArteriovenous Malformationsras ProteinsMAP Kinase Signaling SystemHumansAnimalsHEK293 CellsProtein Kinase InhibitorsPyrimidinonesPyridonesFemaleMale

Stichwörter der Autor:innen

Arteriovenous malformationRAS-MAPK pathwayRIT1TrametinibVascular anomaliesVascular malformation

Substanzen

RIT1 protein, humanras ProteinstrametinibProtein Kinase InhibitorsPyrimidinonesPyridones

Autor:innen und Institutionen

  • Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, VASCERN VASCA European Reference Centr…
  • Institute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany.
  • Institute of Pathology and Tissue Medicine, University of Bern, Bern, Switzerland.
  • Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
  • Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians University Munich, Pettenkoferstr 9, 80336, Munich, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft
  • DFG Walter Benjamin Fellowship
  • German Federal Ministry of Education and Research (BMBF)
  • Swiss National Research Foundation, Synergia grant
  • Charity cycling tour “Tour der Hoffnung”
  • Universitätsklinikum Freiburg

Zitieren

APA

Kapp, F. G., Bazgir, F., Mahammadzade, N., Mehrabipour, M., Vassella, E., Bernhard, S. M., Döring, Y., Holm, A., Karow, A., Seebauer, C., Platz Batista da Silva, N., Wohlgemuth, W. A., Oppenheimer, A., Kröning, P., Niemeyer, C. M., Schanze, D., Zenker, M., Eng, W., Ahmadian, M. R., …, & Rössler, J. (2024). Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition. Angiogenesis, 27(4), 739-752. https://doi.org/10.1007/s10456-024-09934-8

Vancouver

Kapp FG, Bazgir F, Mahammadzade N, Mehrabipour M, Vassella E, Bernhard SM, et al. Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition. Angiogenesis. 2024;27(4):739-752. doi:10.1007/s10456-024-09934-8

BibTeX
@article{Kapp2024,
  author = {Kapp, Friedrich G and Bazgir, Farhad and Mahammadzade, Nagi and Mehrabipour, Mehrnaz and Vassella, Erik and Bernhard, Sarah M and Döring, Yvonne and Holm, Annegret and Karow, Axel and Seebauer, Caroline and Platz Batista da Silva, Natascha and Wohlgemuth, Walter A and Oppenheimer, Aviv and Kröning, Pia and Niemeyer, Charlotte M and Schanze, Denny and Zenker, Martin and Eng, Whitney and Ahmadian, Mohammad R and Baumgartner, Iris and Rössler, Jochen},
  title = {Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition},
  journal = {Angiogenesis},
  year = {2024},
  volume = {27},
  number = {4},
  pages = {739--752},
  doi = {10.1007/s10456-024-09934-8}
}
Kostenlos starten →